| HOME >> MEDICINE >> TECHNOLOGY |
BECTON DICKINSON AND COMPANYCONSOLIDATED INCOME STATEMENTS(Unaudited; Amounts in thousands, except per share data)Nine Months Ended June 30,20122011% ChangeREVENUES
$
5,741,211
$
5,595,8562.6Cost of products sold2,789,0442,654,0815.1Selling and administrative 1,439,0941,343,9467.1Research and development343,968344,989(0.3)TOTAL OPERATING COSTSAND EXPENSES4,572,1064,343,0165.3OPERATING INCOME1,169,1051,252,840(6.7)Interest income38,37941,294(7.1)Interest expense(99,367)(61,685)61.1Other income (expense), net2,392(8,436)NM INCOME FROM CONTINUING OPERATIONS BEFOREINCOME TAXES1,110,5091,224,013(9.3)Income tax provision275,260308,177(10.7)INCOME FROM CONTINUING OPERATIONS835,249915,836(8.8)INCOME FROM DISCONTINUED OPERATIONSNET OF INCOME TAX PROVISION OF$22,158 AND $26,338, RESPECTIVELY45,63555,179(17.3)NET INCOME
$
880,884
$
971,015(9.3)EARNINGS PER SHAREBasic:Income from continuing operations
$
4.02
$
4.11(2.2)Income from discontinued operations
$
0.22
$
0.25(12.0)Net income
$
4.24
$
4.36(2.8)Diluted:Income from continuing operations
$
3.95
$
4.02(1.7)Income from discontinued operations
$
0.22
$
0.24(8.3)Net income
$
4.17
$
4.26(2.1)AVERAGE SHARES OUTSTANDINGBasic207,605222,674Diluted211,254227,782NM - Not Meaningful
Becton Dickinson and CompanySupplemental Income Statement Information - Fiscal 2012Revised for discontinued operations of Discovery Labware divestiture(Unaudited: Amounts in thousands, except per-share data)Amountsreclassified toPreviously DiscontinuedAsReportedOperationsRevisedQuarter 1Revenues
$
1,887,645
$
55,925
$
1,83
'/>"/>
| SOURCE BD (Becton, Dickinson and Company) Copyright©2012 PR Newswire. All rights reserved |